Oxford Biomedica
Oxford Biomedica is a biopharmaceutical company that specializes in the development and commercialization of gene therapy products. The company was established in 1995 and is based in Oxford, United Kingdom. Oxford Biomedica uses its proprietary Lentiviral vector technology platform to deliver genetic material into cells to either correct a genetic defect, or to enhance the cells' properties for therapeutic benefit.
History
Oxford Biomedica was founded by Alan Kingsman and Susan Kingsman, both of whom were professors at the University of Oxford. The company was initially established to commercialize the research conducted by the Kingsmans in the field of gene therapy.
Technology
Oxford Biomedica's primary technology platform is the Lentiviral vector system. This system is used to deliver genetic material into cells, which can then be used to correct genetic defects or enhance the cells' properties for therapeutic benefit. The company's Lentiviral vectors are capable of delivering large amounts of genetic material and can target both dividing and non-dividing cells, making them suitable for a wide range of therapeutic applications.
Products
Oxford Biomedica has developed several gene therapy products, including ProSavin, a treatment for Parkinson's disease, and OXB-102, a treatment for Amyotrophic lateral sclerosis. The company is also involved in the development of gene therapies for other diseases, including cancer, age-related macular degeneration, and cystic fibrosis.
Partnerships
Oxford Biomedica has established partnerships with several major pharmaceutical and biotechnology companies, including Novartis, Sanofi, and Axovant Sciences. These partnerships have enabled the company to advance its gene therapy products through clinical development and towards commercialization.
See also
References
External links
- Oxford Biomedica logo.jpg
Oxford Biomedica logo
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
